Public Perception of Genetic Engineering: Insights Before and After the CRISPR Era

The introduction of CRISPR-Cas9 in 2012 was a groundbreaking moment in the field of genetics, offering a more accessible method for precise genome modifications. This advancement has not only transformed genetic research but also ignited debates on the ethical implications of modifying human and animal genomes. There’s been a surge in both scientific and public interest, leading to extensive studies aimed at gauging public opinion on genetic engineering.
A recent systematic review sheds light on the evolving public perceptions towards genetic modification both before and after CRISPR-Cas9’s debut. Conducted over a span of 35 years, the review chronicled public attitudes in various regions, including Asia, Europe, and North America, through an in-depth examination of questionnaire surveys. You can access the original study for more details here.
Before CRISPR, public discussions largely revolved around the potential medical applications of genetic engineering in humans, such as gene therapies aimed at curing genetic diseases. Conversely, the idea of genetic enhancement in humans was met with skepticism and often outright rejection. The public’s concern centered on ethical considerations, such as the naturalness of altering the human genome and potential societal impacts.
Post-CRISPR, while the overall acceptance of genome editing for treating diseases has increased, attitudes remain mixed regarding non-therapeutic enhancements. The differentiation between therapeutic and non-therapeutic uses remains significant; there’s strong support for treating severe genetic conditions but hesitance and ethical reservations persist regarding enhancements, such as altering intelligence or physical attributes.
The stance on genetically modifying animals similarly hinges on intended use—medical applications, such as producing organs for transplantation, receive higher acceptance compared to the use of genetic changes for food production.
The relationship between public awareness and attitude is complex. Generally, better-informed individuals tend to show greater support for genetic technologies, although this correlation is sometimes weak.
This comprehensive review also highlights methodological aspects of the surveys included, underscoring the need for standardized approaches to ensure consistency across future studies.
As genetic engineering technologies like CRISPR continue to advance, public consultation will be crucial, especially as these applications may directly impact everyday lives. This review underscores the importance of inclusive dialogue and informed policy-making to align technological innovation with societal values and expectations.
For more detailed insights, the original study and its supplementary materials offer further context and understanding of this evolving landscape.

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

How Bluerate.ai Is Transforming the Mortgage Experience With AI

Bluerate.ai—formerly MyMortgageRates—is stepping into 2025 with a mission to modernize a mortgage process that has barely changed in decades. Built by Zeitro, the platform equips both borrowers and loan officers with powerful AI tools, from online pre‑qualification and automated financial data extraction to instant guideline answers and scenario analysis. With more than 3,000 verified NMLS‑licensed loan officers and real‑time rate comparisons from major lenders, Bluerate.ai is quickly becoming a must‑know platform for mortgage and real estate professionals seeking speed, clarity, and a fully digital lending experience.

Federal Housing Programs Restart After Shutdown — Here’s What Real Estate Pros Need to Know Now

After the longest government shutdown in U.S. history, key federal housing programs such as FHA, VA, USDA, and NFIP are officially back in operation—offering long‑awaited relief to agents, lenders, and insurance professionals. But with a six‑week backlog slowing everything from loan guarantees to flood-insurance renewals, real estate pros should brace for delays and focus on resetting client expectations. A new federal spending deal restores funding through early 2026 and gives the market room to breathe, while NAR’s aggressive advocacy helped push the government toward reopening. Now, professionals who communicate clearly and stay on top of regulatory updates will be best positioned to guide clients through the temporary turbulence.

The Digital Wave Transforming Commercial Real Estate

Commercial real estate is rapidly shifting toward a digital-first model, with platforms like Crexi leading the charge. By unifying property data, AI-driven insights, transparent bidding, and streamlined transaction tools, digital marketplaces are becoming essential to how modern CRE deals are sourced, analyzed, and closed. With more than 2 million monthly users and over $1 trillion in facilitated transactions, Crexi showcases how technology is reshaping the industry and giving real estate professionals a powerful competitive edge.

Europe’s Real Estate Giants Unite to Build a Game‑Changing Proptech Accelerator

Europe’s biggest landlords—including Aroundtown, Vonovia, and top global investors—have teamed up to launch ATechX, a powerful new accelerator giving proptech startups something they rarely get: access to real buildings, real customers, and a clear path to scale across multiple countries. Designed to move founders beyond “pilot purgatory,” ATechX offers a true sandbox for innovation in Europe’s aging, regulation‑heavy property market, helping promising technology reach commercial traction faster than ever.

Is Now the Moment to Buy? What Today’s Odd-but-Opportunistic Housing Market Really Means for You

Mortgage rates are finally easing, inventory is climbing, and buyers are gaining leverage for the first time in years — yet sky‑high prices and economic jitters are keeping many on pause. With economists warning that inflation could push rates higher again, this fall may offer a rare window for well‑prepared buyers. Here’s what’s driving the shift, where opportunities are emerging, and how real estate professionals can stay ahead.

Griffin Funding Brings on New SVP to Drive Bold $3B Non-QM Expansion

Griffin Funding has appointed John Jones as Senior Vice President of Growth and EOS Integrator, aiming to scale the company toward a $3 billion annual non-QM volume goal by 2030. After serving in fractional leadership roles since April 2025, Jones now steps in full‑time to lead organizational structure, efficiency, market expansion, and cross‑department alignment. Backed by strong liquidity and rising deal volume, Griffin Funding appears positioned for major industry impact in the years ahead.